• Login Points
  • I recently had an amazing conversation with David Wood on the Healthevity podcast. David, a visionary in the fields of transhumanism, longevity, and the future of humanity, shared his insights on a broad range of topics.

    We delved deep into discussions about the impact of technology on human evolution, the transformative power of education,…Read More

  • Merck bolsters neurodegeneration program with Caraway acquisition

    Companies agree deal worth up to $610m for preclinical pipeline targeting genetically defined neurodegenerative diseases.
    Preclinical biopharma Caraway Therapeutics is to be acquired by pharma giant Merck in a deal worth up to $610 million. The companies revealed that a…Read More

  • Loyal gets promising FDA feedback on lifespan extension drug for dogs

    Company founder says FDA has formally accepted that a drug can be developed and approved to extend lifespan.
    In a blog post this week, Celine Halioua, the founder and CEO of dog longevity biotech Loyal, revealed that the company has received what it believes to be the…Read More

  • Biolexis lands $10m to advance metabolic drug program with longevity potential

    Company is developing metabolic drug candidates targeting obesity, diabetes and human longevity.
    AI-driven drug discovery company Biolexis Therapeutics has closed a $10 million Series A funding round, supporting its mission to advance metabolic drug development.…Read More

  • Interface Bio emerges with $3m to harness the microbiome against inflammation

    AI-powered platform identifies bacterial natural products with the potential to modulate the immune system and reduce inflammation.
    Biotech startup Interface Biosciences has secured $3 million in an oversubscribed seed funding round to advance its AI drug discovery…Read More

  • Insilico announces first-in-human study for oral PHD inhibitor for IBD

    Biotech aims to accelerate clinical trials to reach unmet clinical needs for inflammatory bowel disease.
    Insilico Medicine, a generative AI-driven clinical-stage biotech, has announced it has initiated the first-in-human study for ISM5411, a potentially first-in-class PHD…Read More

  • Stanford organ aging study spawns new longevity startup

    Teal Omics founded after researchers develop algorithm that measures how fast individual organs are aging.
    A study led by researchers from Stanford Medicine, published this week in Nature, has unveiled a new method to predict the biological aging rates of individual organs. By analyzing…Read More

  • Load More Posts

Media

User Badges

Gamipress User Balance
1425 Points
0 XPs